Develop your idea, concept or innovation
Whenever you are excited about an idea, an innovation or (the possibility of) an invention, the first step to take is talk to one of the IXA business developers. Even if your idea is still premature and very much ‘under construction’. The sooner you let us know, the better – in particular when protection of intellectual property is at stake. We can inform you about the do’s and don’ts with respect to making your research data and results public.
We have specialized business developers for each research field. From engineering, maths and life sciences to the arts, humanities and social sciences*. They will support you in assessing the opportunities and potential pitfalls of your idea and advise you on the steps to be taken. Questions you can expect from our team are:
- Is practical application possible? Are there interested external parties?
- What problem is addressed and what solution do you offer?
- Are similar products or services already available? If so, what makes this idea, invention or innovation stand out?
- What could be potential revenues, commercial and/or societal?
The best approach to further advance your idea depends largely on the idea itself and its stage of development. IXA assist in various steps:
- search for partners for further development;
- participate in negotiations for research collaborations or licensing agreements; and
- help to set up contracts dealing with research and development, intellectual property rights, confidentiality, exchanging materials;
- assist in securing funding.
In due time, we can assist in matchmaking with companies and investors with expertise, resources, and effective business networks. In addition, IXA can assist you with legal and financial matters throughout the entire collaboration process.
Lets us help you to develop your idea and bring it to fruition.
* IXA has compiled valorisation guides especially tuned to researchers in social sciences and humanities (SSH) and life sciences (medical technology). Read more here.
A story of VU startup Fitsurance
Fitsurance and how they ‘pivot’ during COVID-19, as a VU ‘personal health’ startup All was lost (well, almost) After a great pilot-project in Zeeland, where we measured runners on the beach, to see what a 3-day running event did with runners’ health, we stepped up our efforts to prepare for 2020, in order to make […]
News
Haermonics ontvangt investering voor betere zorg na openhartchirurgie
Haermonics, een spin-off van Amsterdam UMC, heeft de effectiviteit en veiligheid bewezen van het spoelen van het hartzakje na een openhartoperatie. Een experimentele opstelling zorgde voor significant minder bloedingsgerelateerde complicaties. BOM Brabant Ventures en GAP Technologies investeren in het bedrijf voor de verdere ontwikkeling van de apparatuur en de disposables. Haermonics blijft samenwerken met Amsterdam […]
News
Amsterdam UMC and AlphaBiomics initiate collaboration to validate biologics treatment response predictor RxSelexTM in patients suffering from inflammatory bowel disease
This collaboration is part of 2-year UK government-funded project to bring RxSelexTM closer to patients Amsterdam UMC and AlphaBiomics Ltd., a United Kingdom (UK)-based precision medicine company, have initiated a collaboration to personalize care in patients suffering from inflammatory bowel disease (IBD). IBD patient response to biologics therapy is highly variable, with some patients receiving long-term benefits, […]
News